ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1569

Isotretinoin Induced Seronegative Spondyloarthropathy: Magnetic Resonance Imaging As Diagnostic and Prognostic Biomarker

Basant Elnady1,2, Dalia Desouky3,4, Tohamy Elkhouly5,6, Noha Dawoud7,8 and Hanady Kewan9,10, 1Assistant professor of rheumatology and rehabilitation, department of rheumatology and rehabilitation ، faculty of medicine, Benha university, Benha, Egypt, 2Rheumatology consultant ,Rheumatology division ,Al Hada Armed Forcec Hospital, Taif, Saudi Arabia, 3Assistant professor of public health  and community medicine,department of public health and community medicine,Faculty of medicine, menoufia University, menoufia, Egypt, 4Assistant professor of public health and community medicine, department of family and community medicine، faculty of medicine, taif university, Taif, Saudi Arabia, 5Assistant professor of radiology, radiology department ، faculty of medicine, Benha university, Benha, Egypt, 6Radiology consultant , Department of radiology ,Alhada Armed Forces Hospital, Taif, Saudi Arabia, 7department of dermatology , andrology, and STDs, faculty of medicine, Menoufia university, menoufia, Egypt, 8department of dermatology, Alhada armed forces hospital, Tafi, Ksa, taif, Saudi Arabia, 9Department of radio-diagnosis, Faculty of medicine, Mansoura University., Mansoura, Egypt, 10Radiology consultant ,Department of radiology, Al Hada Armed Forces Hopital, taif, Saudi Arabia

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Magnetic resonance imaging (MRI) and seronegative spondyloarthropathy

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 6, 2017

Title: Spondyloarthropathies and Psoriatic Arthritis – Pathogenesis, Etiology Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

Recent data has revealed occurrence of musculoskeletal manifestations in particular sacroiliitis and inflammatory back pain (IBP) secondary to isotretinoin therapy for acne valgaris, accordingly our study conducted to detect the prevalence of isotretinoin triggered rheumatic side-effects, with close clinical and radiological follow up to assess the drug impact on musculoskeletal system.

Methods:

513 acne patients on isotretinoin therapy were enrolled from dermatology out patients’ clinic, screened for musculoskeletal manifestations related features resulting from isotretinoin therapy, all patients were HLA B27 negative. At baseline C-reactive protein (CRP), Magnetic resonance imaging (MRI) sacroiliac joint, onset of IBP and pain score were reported. MRI proven sacroiliitis, has been scored with semi-quantitative score. Clinical and radiological follow up of our patients were done, patients who met ASAS classification criteria for spondyloarthropathy (SpA) were assessed for disease activity by Ankylosing Spondylitis Disease Activity Score (ASDAS) (3). MRI for sacroiliac joints and CRP were repeated three weeks after being symptomless, with isotretinoin discontinuation.

Results:

513 acne patients were enrolled, 123 (23.9%) developed IBP, and 88 (17.1%) developed arthralgia and arthritis .The mean onset of IBP was (2.1±0.85) months, with mean baseline pain score of (4.34±3.09). MRI proven sacroiliitis was found in (0.13%) of total number of acne patients, and (42.27%) of symptomatic patients, baseline CRP was (32.05±17.23 mg/L) and (3.4±2.7 mg/L) after being symptomless. 51.9% of the symptomatic patients had fulfilled the ASAS criteria for axial SpA, 97.6% of patients were treated with NSAID, however 2.4% were treated with anti TNF biologic. all cases normalized within 9 months, the mean time of normalization was (6.27±1.7) months. There was significant positive correlation for MRI scores, with pain, ASAS scores, baseline CRP. Unilateral sacroiliitis patients had significant rapid improvement than bilateral sacroiliitis (P<0.05).

Conclusion: Isotretinoin induced SpA is quite common side effect .Early rheumatologic assessment, and intervention is recommended. MRI is the modality of choice in early detection, and follow up of isotretinoin induced sacroiliitis.



Disclosure: B. Elnady, None; D. Desouky, None; T. Elkhouly, None; N. Dawoud, None; H. Kewan, None.

To cite this abstract in AMA style:

Elnady B, Desouky D, Elkhouly T, Dawoud N, Kewan H. Isotretinoin Induced Seronegative Spondyloarthropathy: Magnetic Resonance Imaging As Diagnostic and Prognostic Biomarker [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/isotretinoin-induced-seronegative-spondyloarthropathy-magnetic-resonance-imaging-as-diagnostic-and-prognostic-biomarker/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/isotretinoin-induced-seronegative-spondyloarthropathy-magnetic-resonance-imaging-as-diagnostic-and-prognostic-biomarker/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology